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Toll-like receptors (TLRs) play important roles in innate immunity. Several TLR family members have recently been shown to be
expressed by neurons and glial cells in the adult brain, and may mediate responses of these cells to injury and infection. To address the
possibility that TLRs play a functional role in development of the nervous system, we analyzed the expression of TLRs during different
stages of mouse brain development and assessed the role of TLRs in cell proliferation. TLR3 protein is present in brain cells in early
embryonic stages of development, and in culturedneural stem/progenitor cells (NPC).NPC fromTLR3-deficient embryos formedgreater
numbers of neurospheres comparedwith neurospheres fromwild-type embryos. Numbers of proliferating cells, as assessed by phospho
histoneH3 and proliferating cell nuclear antigen labeling, were also increased in the developing cortex of TLR3-deficientmice compared
with wild-type mice in vivo. Treatment of cultured embryonic cortical neurospheres with a TLR3 ligand (polyIC) significantly reduced
proliferating (BrdU-labeled) cells and neurosphere formation in wild type but not TLR3/-derived NPCs. Our findings reveal a novel
role for TLR3 in the negative regulation of NPC proliferation in the developing brain.
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Introduction
The family of mammalian toll-like receptors (TLRs) includes at
least 12membrane proteins that sense the invasion of pathogenic
microorganisms and trigger innate immune responses through
nuclear factor-B (NF-B)-dependent and interferon regulatory
factor (IRF)-dependent pathways (Akira, 2006). TLRs were also
shown to recognize endogenous ligands (Wagner, 2006). For
TLR2,3 and4 many different endogenous ligands have been
described (Rifkin et al., 2005) including heat-shock proteins or
mRNA that are present after the integrity of an adjacent cell has
been compromised, aswell as proteins normally present in tissues
such as hyaluronan or fibrinogen (Smiley et al., 2001; Termeer et
al., 2002). TLRs are present in the brain, where their expression
was initially believed to be limited to glial cells (Lehnardt et al.,
2002; Babcock et al., 2006). However, recent evidence suggests
that neurons and neural progenitor cells also express TLRs (Ma et
al., 2006; Rolls et al., 2007; Tang et al., 2007). Data suggest that
neurons express several TLRs responsive to viral RNAor bacterial
proteins including TLR2, TLR3, TLR4 and TLR8 (Lafon et al.,
2006; Ma et al., 2006; Tang et al., 2007). TLR2 and TLR4 are
expressed in cerebral cortical neurons where their levels and
downstream signaling via JNK are increased in response to en-
ergy deprivation in cell culture and ischemia in vivo (Tang et al.,
2007). Selective elimination of TLR2 or TLR4 function sup-
presses activation of pro-apoptotic JNK and protects cortical
neurons against death induced by energy deprivation and stroke.
TLR2 expression increased rapidly in neurons within the first few
hours after a stroke, well before its upregulation in microglia
(Tang et al., 2007).
In contrast to their established roles in the immune and ner-
vous systems of adult animals, the roles of mammalian TLRs in
development are unknown. Several TLRs have been reported to
be expressed in the developing nervous system. TLR8 is dynam-
ically expressed duringmouse brain development and localizes to
neurons and axons where it may regulate neurite outgrowth and
apoptosis (Ma et al., 2006). TLR2 andTLR4 are expressed in adult
NPC and may influence their proliferation and differentiation
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(Rolls et al., 2007). TLR2 deficiency in mice impaired hippocam-
pal neurogenesis, whereas the absence of TLR4 resulted in en-
hanced proliferation and neuronal differentiation (Rolls et al.,
2007). However, roles for TLR3 in brain development have not
yet been established. Here we show, using TLR3-deficient mice
and components of the TLR3 signaling pathway, that TLR3 is a
negative regulator of NPC proliferation in the developing mouse
brain.
Materials andMethods
Animals.C57BL/6mice, TLR3 knock-outmice (B6;129S1-Tlr3tm1Flv/J)
and wild type mice (TLR/) of the same genetic background
(B6129SF1/J) were purchased from The Jackson Laboratories and were
maintained in our animal facility under pathogen-free conditions on a
12 h light/12 h dark cycle with continuous access to food and water.
Embryos of different gestational ages were collected from pregnant mice
for tissue analysis. Neurosphere cultureswere prepared using brain tissue
from C57B/6, TLR3/ and TLR/ mice. All procedures were ap-
proved by the National Institute on Aging Animal Care and Use
Committee.
Immunostaining. These procedures were similar to those described
previously (Lathia et al., 2007). Briefly, embryonic brains were fixed in
4% paraformaldehyde in PBS overnight at 4°C before being transferred
to sequential 20% and 30% solutions of sucrose (w/v) at 4°C until the
brains sank to the bottom of the solution. The brains were embedded in
TissueTek (Sakura) before sectioning (6 m sections made using a Leica
CM3050S cryostat) in the coronal anatomical plane. Sections were first
exposed for a minimum of 30 min to PBS containing 0.1% Triton X-100
(Amresco) and 10% normal goat serum (Sigma) to block nonspecific
antibody binding, followed by incubation overnight with the relevant
primary antibodies at 4°C. Sections were then incubated with the appro-
priate species-specific Alexa Fluor 488- or 568-conjugated IgG (1:200–
1:500, Invitrogen) antibodies in the dark at
room temperature (RT) for 1 h, and counter-
stained with Hoechst 33342 (0.05 mg/ml solu-
tion in deionized water, Invitrogen). Images
were acquired using a MagnaFire camera and
analyzed using Photoshop (Adobe) software.
For staining of cultured cells, the cells were first
fixed with 2% paraformaldehyde at RT for 30
min, followed by three washes in PBS and incu-
bation with primary and secondary antibodies
as described above. The following antibodies
were used for immunohistochemistry: anti-
TLR3 (1:100, CSA 790; Stressgen), anti-
phospho histone H3 (PH3, 1:500, 06–570; Mil-
lipore), anti-proliferating cell nuclear antigen
(PCNA, 1:500, ab29; Abcam), anti-3-tubulin/
TUJ1 (1:500, T5076; Sigma), anti-GFAP (1:200,
G3893; Sigma), anti-Sox 2 (1:100, MAB2018; R
& D Systems), anti-CNPase (1:250, clone 11–
5B; Sigma). In vivo analysis for PH3 staining
was done by quantifying the number of positive
cells in the entire extent of the embryonic day
(E) 13.5 dorsal telencephalon in 3 separate sec-
tions from 7 TLR/ and 6 TLR3 /mice. In
vivo analysis for PCNA staining was done
blindly by quantifying the amount of positive
cells in a 100 by 200 m (width by height) area
from the center of the E13.5 and E16.5 dorsal
telencephalon and expressed as an average
based on 3 separate sections from 5 control and
TLR3 /mice.
Immunoblot analysis. These procedures were
similar to those described previously (Tang et
al., 2007). Brain tissue protein was extracted us-
ing T-PER tissue protein extraction buffer con-
taining a protease inhibitor mixture (Sigma).
Protein concentration was determined by using
a BCA protein assay kit (Pierce). Protein in samples (40 g) was sepa-
rated by SDS-PAGE (8–12%) and transferred to a nitrocellulose mem-
brane. The membrane was blocked in 5% nonfat milk for 1 h at RT,
followed by an overnight incubation at 4°C with primary antibodies:
TLR2 (1:1000, 2229; Cell Signaling Technology), TLR3(1:1000, 2253;
Cell Signaling Technology), TLR4 (1:1000, 2246; Cell Signaling Technol-
ogy), IRF3 (1:1000, 4962; Cell Signaling Technology), actin (1:1000,
A5441; Sigma), synaptophysin (1:2000, SY38; Sigma), -tubulin
(1:10,000, T6074; Sigma). The membrane was then washed and incu-
bated with a secondary antibody for 1 h at RT. Protein bands were visu-
alized using a chemiluminescence detection kit (GE Healthcare).
Neurosphere cell culture. NPCs from the cortex were propagated as
free-floating aggregates [neurospheres (NP)], to promote proliferation
of neural stem and progenitor cells before use in experiments. In brief,
the dorsal telencephalon from E12.5, E13.5, or E14.5 mouse embryos
were isolated, mechanically dissociated, and seeded at a density of
200,000 cells/ml in a T75 flask containing DMEM/Ham’s F-12 medium,
supplemented with B27 (1:50; Invitrogen), epidermal growth factor
(EGF), and fibroblast growth factor (FGF)-2 (both at 20 ng/ml; R & D
Systems). After neurospheres had grown for 7 d in culture, cells were
dissociated using the NeuroCult cell dissociation kit (StemCell Technol-
ogies) and plated into 96 wells plates (Nunc), at 1000 cells per well. For
adult neurosphere cultures, coronal sections (2-mm-thick) of tissue con-
taining the subependymal zone were obtained from the brains of adult (2
month) C57BL/6 mice. The tissue was incubated for digestion at 37°C,
5% CO2 for 10 min in HBSS containing 2 mg/ml trypsin (Sigma). The
trypsin was subsequently decanted and digestion was stopped with addi-
tion of HBSS containing 2 mg/ml trypsin inhibitor (Sigma), and the
tissue was minced and mechanically dissociated by pipette trituration.
Cells obtained from single cell suspensions were seeded and cultured as
described above.
Neurospheres which formed were counted after 7 d in culture and the
Figure 1. Expression of TLR2, TLR3 and the TLR3-regulated transcription factor IRF3 in the developing brain. A, Immunoblot
showing relative levels of TLR2 (95 kDa), TLR3 (95 kDa), and IRF3 (55 kDa) in lysates of cortical tissue collected from mice at the
indicated stages of development (E, embryonic; P, postnatal). B, Immunoblot showing relative levels of TLR2 (95 kDa), TLR3 (95
kDa), and IRF3 (55 kDa) in lysates of neurospheres (NP) derived fro E12.5 mice, and dissociated cell cultures established from
neurospheres (days 1–7 after plating in differentiation-promoting conditions).
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average of 8 wells was taken per experimental
condition. Neurosphere forming assays for
E13.5 wild-type (WT) andTLR3 /NPCwere
done in triplicate; each replicate consisted of a
pool of embryos from the same litter. Neuro-
sphere forming assays for E14.5 C57BL/6 NPC
stimulated with polyIC were done a minimum
of 5 times, each sample consisted of a pool of
embryos from the same litter. To induce differ-
entiation, growth factors were withdrawn, and
neurospheres were plated on poly (D-lysine)
and laminin-111 (10 g/ml; Sigma)-coated
eight-well chamber slides (Nunc) for 7 d before
immunostaining.
Neurosphere diameter measurements. To
measure neurospheres diameter, pictures of 10
wells of each experimental condition were
taken using a Magnafire camera. Images were
then analyzed using NIH ImageJ software
(http://rsbweb.nih.gov/ij/).
Viability assay.NPC cultures were incubated
with 10MResazurin dye (Sigma) for 30min at
37°C. Fluorescence was thenmeasured using an
HTS 7000 plus (Perkin-Elmer) plate reader
with a 540 nm excitation and 595 nm emission
wavelengths.
Reverse transcriptase-PCR for TLR3. Total
RNAwas isolated from 600,000 cells fromNPC
derived from E14 embryonic and adult WT
mice using the QiaZol reagent (Qiagen). Re-
verse transcription of RNA to cDNA was per-
formed using SuperScript III First-Strand Syn-
thesis SuperMix (Invitrogen). The cDNA
synthesized was subjected to PCR amplification
using Platinum Blue PCR SuperMix (Invitro-
gen) with TLR3 primers pair (forward: 5 agctt-
tgctgggaactttca 3; reverse: 5 gaaagatcgagct-
gggtgag 3; 127bp) and was normalized against
-actin (forward: 5 tggaatcctgtggcatccatgaaac
3; reverse: 5 taaaacgcagctcagtaacagtccg 3, 348
bp). PCR was performed using PTC-200 (MJ
Research) PCR system and visualized by
ethidium bromide stained 2% TAE-agarose gel
electrophoresis. PCR amplification consisted of
30 cycles of 30 s denaturation at 94°C, 1m an-
nealing at 54°C, and 30 s of elongation at 72°C.
PCR products quantified using NIH ImageJ
software.
Statistical analysis. Experimental results are
expressed as mean SEM. Statistical compari-
sons were made with ANOVA, followed by
Newman–Keuls post hoc analysis for pairwise
comparisons.
Results
TLR3 expression is high during early
brain development
To determine whether TLR expression
changes during brain development, we
first measured levels of several TLR pro-
teins in mouse cortical tissues of different embryonic and early
postnatal stages. In the telencephalon, neurogenesis commences
at E11 and peaks between E14 and E16; during this period of time
there is first a rapid expansion of NPC followed by the generation
of neurons via asymmetric divisions [for review, see Go¨tz and
Huttner (2005)]. Hence, at these early stages of brain develop-
ment, the majority of cells in the cortex are NPCs and over time,
the number of neurons increases. Immunoblot analysis demon-
strated that the TLR3 protein was present in relatively high
amounts at E12.5, and its levels decreased through E17.5, match-
ing the rate of decreased NPC expansion (Fig. 1A). However, the
TLR2 protein was very low in the developing cortex at E12.5 or
E13.5, but increased gradually from E15.5 to neonatal stages,
corresponding to NPCs gradually differentiating as brain devel-
opment proceeds (Fig. 1A). Further immunoblot analysis
showed that as neuronal maturation commences, as assessed by
Figure 2. TLR3 is present in relatively high amounts in cells in the proliferative regions of the developing cerebral cortex. A,
Strong TLR3 immunoreactivity (green) is present in cells throughout the neuroepithelium at E10.5. B, TLR3 immunoreactivity
(green) is present in cells throughout the cortex at E13.5. C, Expression of TLR3 (green) in the E16.5 cortex; cells were counter-
stainedwithHoechst (blue) to label all nuclei andwith the neuron-specificmarker3-tubulin (red). Scale bar, 100m.Note that
TLR3 immunoreactivity ismuch stronger in3-tubulin-negative cells in the proliferative ventricular zone comparedwith the low
TLR3 immunoreactivity in3-tubulin-positive cells.
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synaptophysin expression, the expression of TLR2 protein was
elevated (supplemental Fig. 1, available at www.jneurosci.org as
supplementalmaterial), indicating that TLR2 is likely to be highly
expressed in neurons. In contrast, TLR4 protein levels were de-
tectable at E12.5 and remained at a relatively constant level
throughP13 (supplemental Fig. 1, available atwww.jneurosci.org
as supplemental material).We also determined levels of the tran-
scription factor interferon regulatory factor 3 (IRF3), which is
involved in the TLR3 signaling pathway (Jiang et al., 2004) in the
same brain tissue samples; IRF3 levels were highest at E12.5 and
were decreased considerably after E18.5 (Fig. 1A), again match-
ing the levels of TLR3 protein and decrease in the rate of NPC
expansion. To further evaluate the dynamics of IRF3 and TLR2
and 3 protein levels in response to NPC expansion, we used pro-
liferating neurospheres (NP) as a model system. TLR2 was not
detected in NP derived from E12.5 em-
bryos, but was expressed in cells within 2 d
of culture in differentiation-promoting
conditions (Fig. 1B). In contrast, cells in
NP expressed TLR3 and IRF3 in high
amounts, and levels of TLR3 and IRF3 de-
creased rapidly (within 24 h) after plating
cells in differentiation-promoting condi-
tions (Fig. 1B).
The immunoblot data suggested that
NPC express relatively high amounts of
TLR3 and its downstream signaling effec-
tor protein IRF3, suggesting a potential
role for TLR3 in regulating NPC prolifer-
ation during brain development. Notably,
IRF3 expression was increased in response
to PolyIC treatment inWTbut not inNPC
derived from TLR3-deficient mice (sup-
plemental Fig. 2B, available at www.
jneurosci.org as supplemental material).
To determine the cellular localization of
TLR in the developing cortex in vivo, we
immunostained brain sections of different
agemouse embryos with a TLR3 antibody.
We chose ages that correspond to develop-
mental periods of cortical NPC expansion
(E10.5), and early (E13.5) andmid (E16.5)
embryonic neurogenesis. At E10.5, when
the neuroepithelium consists of dividing
NPC, there was strong TLR3 immunore-
activity throughout the neuroepithelium
(Fig. 2A). TLR3 was also detected in cells
throughout the cortex at E13.5 (Fig. 2B),
and was coexpressed in sox2-positive NPC
in the cortex (data not shown). During
embryonic neurogenesis, TLR3 was still
detected in the NPC-containing region of
the cortex andwasweakly expressed in3-
tubulin positive (neuronal) cells in the
outer regions of the developing cortex
(Fig. 2C). TLR3-deficient embryos at both
E13.5 and E16.5 were negative for staining
with the TLR3 antibody, demonstrating
that the antibody used for in vivo assess-
ment was specific to TLR3 (supplemental
Fig. 2A, available at www.jneurosci.org as
supplemental material).
TLR3 negatively regulates neural progenitor cell proliferation
As we observed enriched expression of TLR3 in early stages of
brain development, we next determined whether TLR3 signaling
affectsNPCproliferation.WeusedNPC-containing neurosphere
cultures to assess the role of TLR3 on proliferation.Neurospheres
derived from E12.5 mice were treated with the TLR3 ligand poly-
cytidylic acid (polyIC; 10 and 20g/ml) and downstream signal-
ingmolecule interferon- (200 and 500U) for 24 h (Alexopoulou
et al., 2001; Matsumoto et al., 2004). Both polyIC and
interferon- significantly reduced the number of BrdU-positive
cells in cultures (Fig. 3A), suggesting that TLR3 activation inhib-
its NPCproliferation.We also assessed neurosphere formation in
the presence of polyIC and relative to a time pregnant control at
E14.5, both 2g/ml and 20g/ml of polyIC reduced the number
of neurospheres which formed (Fig. 3B). We further analyzed
Figure3. TLR3 signaling negatively regulates neural progenitor cell proliferation.A, Treatment of neurosphereswith the TLR3
ligands polycytidylic acid (polyIC) (10 or 20g/ml) and interferon- (200 or 500 U) significantly reduced the number of BrdU-
positive (proliferating) cells. *p  0.05 compared with the control value. B, NPC proliferation relative to control values in
wild-type neurospheres treated with polyIC (2 or 20g/ml) and neurosphere cultures derived from TLR3/mice. Immuno-
fluorescence analysis of differentiated TLR3/neurospheres showing their potential to remainNPCs (C, bottom, sox2, green) or
differentiate into astrocytes (C, bottom,GFAP, red), oligodendrocytes (C, top, CNPase, green), or neurons (C, top,3-tubulin, red).
All images counterstained with Hoechst. Scale bar, 100 m. D, No difference was observed in the percentage of neurons,
astrocytes and oligodendrocytes derived fromWT or TLR3/ (TLR3KO) mice.
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NPC proliferation using E13.5 neuro-
sphere cultures derived from TLR3 mu-
tant mice, along with corresponding wild
type background strain-matched controls.
Neurosphere-forming assays showed sig-
nificantly more neurospheres formed
from TLR3-deficient NPCs (93% in-
crease) compared with wild type controls
(Fig. 3B). To assess the differentiation po-
tential of these neurospheres, they were
plated on laminin111/121 for 7 d in the ab-
sence of growth factors to promote cell dif-
ferentiation. Immunofluorescence analysis
showedthatboth theTLR3/ (Fig. 3C)and
control (data not shown)neurosphereswere
multipotent and capable of giving rise to
neurons, astrocytes, and oligodendrocytes.
There was no significant difference in the
percentage of neurons, astrocytes and oligo-
dendrocytes between WT and TLR3/
NPC (Fig. 3D). In addition, no premature
differentiation was observed in TLR3/
NPC cultures or in the ventricular zone of
TLR3 / embryos (data not shown).
To confirm that the changes in prolif-
eration induced by PolyIC aremediated by
TLR3 signaling, we compared WT and
TLR3/ NPC proliferation following
PolyIC administration. Both primary and
secondary sphere formation was signifi-
cantly higher in NPC derived from
TLR3/ compared with WT mice (Fig.
4A). Although 2 g/ml PolyIC did not significantly alter neuro-
sphere formation, NPCs treated with 10 g/ml exhibited lower
neurosphere formation than WT controls (Fig. 4B). Further-
more, 20 g/ml polyIC significantly depressed neurosphere for-
mation from WT NPC. In contrast, neurosphere formation by
NPCs from TLR3 / mice remained unchanged following
PolyIC administration. Whereas PolyIC did not significantly al-
ter the diameter size of WT NPCs, TLR3/ neurospheres were
significantly larger thanWT neurospheres (Fig. 4C). In addition,
viability was unaltered at low concentrations of PolyIC; however,
20 g/ml PolyIC significantly decreased viability of WT-derived
neurospheres (Fig. 4D). The decrease in viability coincided with
the significant decrease in total neurosphere formation observed
at high PolyIC concentrations (Fig. 4B).
Given the increase in NPC proliferation in cells derived from
TLR3/ embryos, we also assessed the proliferation in vivo by
using markers for different parts of the cell cycle; PCNAmarking
cells in early G1 to S-phase and PH3 marking cells in M-phase.
Proliferation as assessed by PCNA-positive cells was significantly
( p  0.05) increased in E13.5 but not on E16.5 TLR3/ em-
bryos (Fig. 5A). Consistent with this, the number of PH3-
positive cells was also significantly increased in TLR3/ mice
(Fig. 5B) (31.1  1.96 and 37.77  2.89 in WT and TLR3/,
respectively).Collectively, these findings suggest thatTLR3 signaling
inhibits the proliferation of NPC at early (E13.5) embryonic stages
when TLR3 is highly expressed and that this effect is abrogated at
later (E16.5) embryonic stage when TLR3 expression is reduced.
Discussion
TLRs are best known as initiators of the innate immune response
to pathogens and, until recently, it was believed that microglia
and other glial cells were the only intrinsic types of brain cell that
express TLRs and respond to TLR ligands (Bsibsi et al., 2002;
Olson andMiller, 2004). However, recent reports revealed inter-
esting roles for TLRs in the CNS. Several TLRs, including (TLR2,
TLR3 and TLR4) are expressed by primary cortical neurons in
culture and in the adult brain (Lafon et al., 2006; Tang et al.,
2007). TLR2 and TLR4 (but not TLR3) are activated in cortical
neurons in response to oxidative andmetabolic stress resulting in
induction of a pro-apoptotic signaling pathway involving the ki-
nase JNK (Tang et al., 2007). The present findings suggest that
TLR3 may play a particularly important role in the regulation of
NPC proliferation during early stages of development of the ce-
rebral cortex. TLR3 expression was highest in the early period of
cortical development when NPC are highly proliferative, and
then declined as neurogenesis and gliogenesis ensued (mid-
gestation through early postnatal periods). In contrast to TLR3,
TLR2 was not detected at early embryonic stages but showed
strong expression in late embryonic and early postnatal brain,
while TLR4 was expressed at relatively constant amounts in the
brain during embryonic development. The developmental in-
crease of TLR2 expression provides additional support for the
recently reported role of TLR2 in regulating adult neurogenesis
(Rolls et al., 2007). Interestingly, adult neurospheres stimulated
with polyIC did not show a decrease in neurosphere formation
(data not shown) as was seen with embryonic neurospheres, sug-
gesting a context dependent role for TLR2 and 3 in regulating
NPC behavior. Consistent with this adult-derived NPC express
lower levels of TLR3 mRNA compared with embryonic-derived
NPC (supplemental Fig. 3, available at www.jneurosci.org as sup-
plemental material).
Our data suggest that TLR3 signaling inhibits the proliferation
Figure 4. PolyIC depresses neural progenitor cell proliferation through TLR3. A, NPC from TLR3-deficient mice form a signifi-
cantlyhighernumberof bothprimaryand secondaryneurospheres thanWTcontrols.B, TreatmentofneurosphereswithPolyIC (2,
10, or 20g/ml) significantly depressed neurosphere formation at high concentrations, but did not alter neurosphere formation
in cultures derived from TLR3-deficientmice. C, PolyIC administration did not significantly alter neurosphere diameter. However,
neurospheres derived from TLR3-deficient mice are significantly larger than WT mice. D, PolyIC decreased viability of neuro-
spheres derived fromWT animals at 20mg/ml; however, it did not alter viability of TLR3/-derived neurospheres. Differences
are represented asSEM, *p 0.05.
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of embryonic NPC. Consistent with this hypothesis, a TLR3 li-
gand and downstream signaling molecule inhibited the prolifer-
ation of embryonic mouse NPC, and NPC proliferation was in-
creased in the developing cerebral cortex of TLR3-deficientmice.
The activation of TLR signaling pathways originates from the
cytoplasmic Toll/IL-1 receptor (TIR) domain; a proline residue
in the TIR domain is conserved among all TLRs, except for TLR3
(Takeda and Akira, 2004). In the signaling pathway downstream
of the TIR domain, an adaptor protein called myeloid differenti-
ation factor 88 (MyD88) plays a crucial role. The TLR3 ligand
dsRNA has been shown to induce activation of NF-B inMyD88
knock-out cells (Alexopoulou et al., 2001); this MyD88-
independent signaling pathway leads to the activation of the tran-
scription factor IRF3 (Yamamoto et al., 2003). We observed a
correlation between the expression levels of IRF3 and TLR3, such
that both were present in highest amounts in NPC during early
cortical development in vivo and in neurosphere cells in culture.
These data are consistent with the possibility that IRF3 mediates
the inhibition of NPC proliferation in response to TLR3 activa-
tion. Based upon previous findings showing that TLR3/IRF3 sig-
naling induces interleukin-6 (IL-6) production (Kimet al., 2008),
and that IL-6 can affect NPC proliferation (Mondal et al., 2004),
IL-6 is a potential target of IRF3 that might play a role in TLR3-
mediated inhibition of NPC proliferation.
Although present in higher amounts in NPC, TLR3 is also
expressed in the neuronal and glial progeny of the NPC. It was
recently reported that TLR3 is expressed in themouse central and
peripheral neurons where it is concentrated in the growth cones;
activation of TLR3 by the synthetic ligand polyIC or by mRNA
causes growth cone collapse and inhibits neurite extension
(Cameron et al., 2007). The specific mechanism(s) by which
TLR3 signaling inhibits the proliferation
of NPC and the outgrowth of developing
neurons remains to be established. How-
ever, because both cell proliferation and
growth cone motility involve dynamic
changes in the cytoskeleton and mem-
branes, it is possible that TLR3 signaling
inhibits such processes. Indeed, TLR sig-
naling in dendritic cells has striking ef-
fects on endocytosis and the cytoskele-
ton (Watts et al., 2007). Our present
findings identify a previously unknown
role for TLR3 signaling in the negative
regulation of NPC proliferation, a mech-
anism that may control the growth of the
developing cerebral cortex.
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